McKesson Ventures helps innovators build and scale businesses that will lead to stronger, more sustainable future for health care. We partner with companies that are enabling and driving positive change while pursuing high-growth opportunities.
Arjun is an associate on the investment team responsible for evaluating new investment opportunities. Before joining the McKesson Ventures team, he started out his career doing investment banking at Moelis & Company, working on M&A and restructuring transactions across the spectrum of healthcare.
Ashley is responsible for deal sourcing, diligence, and supporting portfolio management. She brings nearly a decade of experience working with innovative healthcare services and technology companies as an investor and operator. Before joining McKesson Ventures, Ashley was at IBM Watson Health in New York, where she focused on commercializing emerging cognitive technologies in new markets. Prior to that, Ashley was at Sterling Partners, a middle-market private equity firm, where she focused on investing in healthcare services businesses. Ashley began her career in investment banking at Deutsche Bank. Ashley received her BS from the University of Illinois Urbana-Champaign and MBA from Harvard Business School.
Carrie brings over 15 years of healthcare experience from several vantage points within the healthcare industry. Prior to joining McKesson Ventures, she served as Vice President, Strategy and Business Development for Omada Health, where she focused heavily on all elements of commercial strategy and partnerships. Prior to Omada, Carrie held roles within McKesson’s Strategy & Business Development team, advancing innovation strategies aimed at hospital pharmacy and clinical trial patient recruitment. She began her career in drug development managing oncology clinical trials in both large pharmaceutical and biotech settings. Williams holds a MBA from the Haas School of Business at the University of California at Berkeley and a BS in biology from the University of Massachusetts Amherst. After more than a dozen years in the Bay Area, she is now back in the Boston area, where she lives with her husband, daughters, and their golden retriever, Fenway. A piece of her heart will always be in San Francisco, so maybe it’s time to rename the dog “Oracle.”
Dave Schulte is a Senior Vice President and Managing Director and leads McKesson Ventures investing efforts. Previously, he helped grow Kaiser Permanente Ventures from $20M to $400M of assets and managed the investment team. His investments include: Landmark Health (acquired by General Atlantic), SHYFT Analytics (acquired by Medidata), Komodo Health, Aledade, Infusion Express, Omada Health, Proteus Digital Health, Ingenious Med, MetricStream, Pulmonx, AtheroMed (acquired by Phillips) and Torax Medical (acquired by J&J). Dave is a member of: the Harvard Kennedy School Health Policy Leadership Council, the Boehringer Ingelheim Digital Health Advisory Council, the Aspen Institute Society of Fellows and the St. John’s University Private Investment Fund. He is a graduate of St. John’s University and earned a Master of Public Policy from Harvard Kennedy School. Dave grew up in Minneapolis, where he was an all-state soccer and all-conference basketball player. Now he aspires to “all-backyard” in the eyes of his children.
Giselle Erazo is the Executive Assistant to Tom Rodgers and Dave Schulte as well as the office manager for the team. Giselle plays an integral role in managing the day-to-day operations for McKesson Ventures by creating a delightful and hassle-free experience for all guests. She brings over 15 years of experience as an executive assistant and office manager. Giselle has been with McKesson for over 10 years and previously worked in McKesson’s General Counsel Organization and other industries, including venture capital, investment banking and international infrastructure. Giselle is a Bay Area native and lives with her daughter and dog, who thinks he is tough but is the sweetest being at heart. She also enjoys live music, being outdoors and exploring places near and far.
Jennifer brings over 20 years of experience from various roles across the McKesson enterprise ranging from marketing, business development, strategy and sales operations. In addition to investing and supporting health technology and services companies, Jennifer oversees operations for the team which includes talent, budget and portfolio development. Jennifer holds a B.S. in Economics from Boston College. Although born and raised in San Francisco, Jennifer spends harvest season on the family farm cultivating pluots and disrupting the plum and apricot industries.
Mark Padilla is lead counsel for McKesson Ventures. In addition to his role with McKesson Ventures, he is Chief Counsel, Corporate and Securities for McKesson Corporation. In addition, Padilla is principal counsel to the corporation’s Treasury department and works on mergers and acquisitions (M&A) transactions. Previously Padilla spent a decade at Wilson Sonsini Goodrich & Rosati in Palo Alto, CA, representing information technology and life sciences startups in venture capital financings, M&A transactions and IPOs. He also represented public companies, advising them on SEC public disclosure and securities transactions. He possesses a J.D. from the Georgetown University Law Center, a B.A. from Yale University and an undying love of the Los Angeles Lakers.
McKesson is one of the newest recruits for Guide Dogs for the Blind. He is a yellow male Labrador retriever, born on March 10, 2017. He just left campus a week ago to spend the next year with his puppy raisers in Snohomish, Washington. He was named in honor of McKesson Ventures’ recent donation to GDB. Photo credit: Guide Dogs for the Blind.
